{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:59:49Z","timestamp":1784192389457,"version":"3.55.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/inf.0b013e318287fe0d","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T13:14:04Z","timestamp":1359033244000},"page":"604-609","source":"Crossref","is-referenced-by-count":16,"title":["Nearly Complete Elimination of the 7-valent Pneumococcal Conjugate Vaccine Serotypes in Tennessee"],"prefix":"10.1097","volume":"32","author":[{"given":"Natasha B.","family":"Halasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Arbogast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen S.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie R.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Schaffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210202","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/14740338.4.4.631","article-title":"The safety of 7-valent pneumococcal conjugate vaccine.","volume":"4","author":"Ghaffar","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"R4-6-20210202","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","article-title":"The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R5-6-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R6-6-20210202","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/infdis\/171.4.885","article-title":"Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine.","volume":"171","author":"Butler","year":"1995","journal-title":"J Infect Dis"},{"issue":"suppl 2","key":"R7-6-20210202","first-page":"S2","article-title":"Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults.","volume":"24","author":"Black","year":"2006","journal-title":"Vaccine"},{"key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/jama.291.18.2197","article-title":"Active Bacterial Core SurveillanceEmerging Infections Program Network. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.","volume":"291","author":"Flannery","year":"2004","journal-title":"JAMA"},{"key":"R9-6-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R10-6-20210202","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"R11-6-20210202","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/01.inf.0000133046.60555.de","article-title":"Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine.","volume":"23","author":"Talbot","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/498745","article-title":"Trends in invasive pneumococcal disease-associated hospitalizations.","volume":"42","author":"Shah","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R13-6-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R14-6-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Active Bacterial Core SurveillanceEmerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R15-6-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cid\/cir326","article-title":"CDC Emerging Infections Program Network. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.","volume":"53","author":"Rosen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R16-6-20210202","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2008.07.016","article-title":"Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults.","volume":"26","author":"Nelson","year":"2008","journal-title":"Vaccine"},{"key":"R17-6-20210202","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"R18-6-20210202","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422653","article-title":"Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine.","volume":"39","author":"Talbot","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R19-6-20210202","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"R20-6-20210202","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"key":"R21-6-20210202","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.298.15.1772","article-title":"Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.","volume":"298","author":"Pichichero","year":"2007","journal-title":"JAMA"},{"key":"R22-6-20210202","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":"Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.","volume":"26","author":"Pelton","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R23-6-20210202","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1128\/JCM.02321-07","article-title":"Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae in Cleveland: a quarter-century experience.","volume":"46","author":"Jacobs","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R24-6-20210202","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1086\/498043","article-title":"Active Bacterial Core Surveillance Team. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.","volume":"192","author":"Pai","year":"2005","journal-title":"J Infect Dis"},{"key":"R25-6-20210202","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"R26-6-20210202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/INF.0b013e31824214ac","article-title":"Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.","volume":"31","author":"Wroe","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R29-6-20210202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3201\/eid0701.010114","article-title":"Active Bacterial Core Surveillance Team of the Emerging Infections Program Network. Active bacterial core surveillance of the emerging infections program network.","volume":"7","author":"Schuchat","year":"2001","journal-title":"Emerging Infect Dis"},{"key":"R30-6-20210202","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1001\/jama.1991.03460240071030","article-title":"Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population.","volume":"265","author":"Schuchat","year":"1991","journal-title":"JAMA"},{"key":"R31-6-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v035.i04","article-title":"PyMC: Bayesian Stochastic Modelling in Python.","volume":"35","author":"Patil","year":"2010","journal-title":"J Stat Softw"},{"key":"R32-6-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.","volume":"46","author":"Munoz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R33-6-20210202","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"R34-6-20210202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.inf.0000207484.52850.38","article-title":"U.S. Pediatric Multicenter Pneumococcal Surveillance Group. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.","volume":"25","author":"Gonzalez","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R35-6-20210202","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.","volume":"343","author":"Whitney","year":"2000","journal-title":"N Engl J Med"},{"key":"R36-6-20210202","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1128\/AAC.48.8.3016-3023.2004","article-title":"Active Bacterial Core Surveillance Team. Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin.","volume":"48","author":"Schrag","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-6-20210202","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1086\/500941","article-title":"Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia.","volume":"42","author":"Steenhoff","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R38-6-20210202","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.inf.0000253059.84602.c3","article-title":"Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.","volume":"26","author":"Farrell","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R39-6-20210202","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4065\/84.10.871","article-title":"Incidence of invasive pneumococcal disease among children after introduction of a 7-valent pneumococcal conjugate vaccine: a population-based study in Olmsted County, Minnesota.","volume":"84","author":"Tsigrelis","year":"2009","journal-title":"Mayo Clin Proc"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e318287fe0d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:09:42Z","timestamp":1620954582000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201306000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318287fe0d","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}